Bench-to-Bedside Theranostics in Nuclear Medicine.

Area of Science:

• Nuclear Medicine
• Oncology
• Personalized Medicine

Background:

• Theranostics in personalized medicine relies on selecting the right radiolabeled probe for the specific patient and cancer target.
• Molecular imaging and advances in genomic knowledge are crucial for identifying effective theranostic biomaterials.

Purpose of the Study:

• To review important theranostic agents for treating various malignancies.
• To highlight the synergy between molecular imaging and radionuclide therapy in personalized patient care.

Main Methods:

• Review of current literature on theranostic agents.
• Focus on radiopharmaceuticals and molecular biomarkers for targeted therapy.

Main Results:

• Numerous studies report the discovery and application of radiotracers in personalized medicine.
• Theranostic agents offer a paradigm for individualized molecular targeting, diagnosis, and treatment of malignancies.

Conclusions:

• Theranostics represents a powerful approach integrating diagnostics and therapeutics for personalized cancer treatment.
• Further prospective studies are needed to compare theranostics with standard therapies.